Clinical Effect of Alpha-1 Antagonism by Terazosin on External and Internal Urinary Sphincter Function

Authors:

Abstract
The purpose of this investigation was to determine the effectiveness of alpha-1 blockade in the treatment of bladder outlet obstruction in the spinal cord injured (SCI) patient. We evaluated terazosin, a selective alpha-1 blocker, in 15 normotensive SCI patients. Detrusor-external sphincter dyssynergia (DESD), without obstruction of the bladder neck or prostate, was documented in all patients using video-urodynamic evaluation. Urodynamic testing was performed both before and during treatment with terazosin (5 mg nightly). Voiding pressure before and during terazosin therapy averaged 92±17 and 88±27 cm H2O, respectively (p=0.48). After subsequent external sphincterotomy or sphincter stent placement, the voiding pressure was reduced to 38±15 cmH2O (pJ Am Paraplegia Soc; 16: 207–214)

This publication has 38 references indexed in Scilit: